IMPLEMENTING THE GENERALIZED RISK-ADJUSTED COST-EFFECTIVENESS (GRACE) MODEL FOR SICKLE-CELL DISEASE: A CASE STUDY

被引：0
|
作者：
Kleintjens, J. [1 ]
Mulligan, K. [2 ]
Hassan, T. [3 ]
Land, N. [3 ]
May, S. G. [3 ]
Graf, M. [3 ]
机构：
[1] PRECISIONheor, London, England
[2] Univ Southern Calif, Los Angeles, CA USA
[3] PRECISIONheor, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE466
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [1] A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)
    Darius N. Lakdawalla
    Charles E. Phelps
    The European Journal of Health Economics, 2022, 23 : 433 - 451
  • [2] A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)
    Lakdawalla, Darius N.
    Phelps, Charles E.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022, 23 (03): : 433 - 451
  • [3] IMPLEMENTING THE GENERALIZED RISK-ADJUSTED COST-EFFECTIVENESS (GRACE) APPROACH - A CASE EXAMPLE IN HCV THERAPIES
    Graf, M.
    Chou, J.
    Espinosa, Diaz O.
    Brewer, I
    Heim, Z.
    Baumgardner, J. R.
    VALUE IN HEALTH, 2023, 26 (06) : S124 - S124
  • [4] The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation
    Lakdawalla, Darius N.
    Phelps, Charles E.
    JOURNAL OF BENEFIT-COST ANALYSIS, 2023, 14 (01) : 44 - 67
  • [5] Health Technology Assessment With Diminishing Returns to Health: The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Approach
    Lakdawalla, Darius N.
    Phelps, Charles E.
    VALUE IN HEALTH, 2021, 24 (02) : 244 - 249
  • [6] COST-EFFECTIVENESS OF NEONATAL SCREENING FOR SICKLE-CELL DISEASE
    LANE, PA
    ECKMAN, JR
    JOURNAL OF PEDIATRICS, 1992, 120 (01): : 162 - 163
  • [7] NEONATAL SCREENING FOR SICKLE-CELL DISEASE - A COST-EFFECTIVENESS ANALYSIS
    TSEVAT, J
    WONG, JB
    PAUKER, SG
    STEINBERG, MH
    JOURNAL OF PEDIATRICS, 1991, 118 (04): : 546 - 554
  • [8] COST-EFFECTIVENESS OF NEONATAL SCREENING FOR SICKLE-CELL DISEASE - REPLY
    TSEVAT, J
    WONG, JB
    PAUKER, SG
    STEINBERG, MH
    JOURNAL OF PEDIATRICS, 1992, 120 (01): : 163 - 163
  • [9] NEONATAL SCREENING FOR SICKLE-CELL DISEASE - A COST-EFFECTIVENESS ANALYSIS
    STEINBERG, MH
    TSEVAT, J
    WONG, JB
    PAUKER, SG
    CLINICAL RESEARCH, 1988, 36 (03): : A548 - A548
  • [10] Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain
    Castilla-Rodriguez, Ivan
    Cela, Elena
    Vallejo-Torres, Laura
    Valcarcel-Nazco, Cristina
    Dulin, Elena
    Espada, Mercedes
    Rausell, Dolores
    Mar, Javier
    Serrano-Aguilar, Pedro
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (06): : 567 - 575
12345